Back to Natixis Natixis

TXGTXG

Showing 2 of 12 quarters

Position history for NatixisNatixis's holdings in 10x Genomics, Inc.

No. Natixis exited its TXG (10x Genomics) position in Q3 2025. Its Q2 2025 13F listed 300 shares worth $3,474. Natixis first reported TXG in Q4 2020 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3,474

Total Shares Change

-300

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$11.34
0
2025-Q2
New
300
—
$3,4740.0%$11.73
21

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used